Abstract
Recent developments in biotechnology have enabled scientists to modulate DNA sequences in a precise way. These genome engineering technologies also open new possibilities to alter the epigenetic composition of the genome at any given genomic location thereby changing gene expression patterns, while leaving the primary DNA sequence intact. This new approach, so-called epigenetic editing, holds great promise to permanently reprogram cell identity. As reprogramming the epigenetic composition, and hence gene expression patterns is now technically feasible, the society needs to consider to what extent interference at the epigenetic level can be accepted. In this review, we discuss the potential epigenetic editing holds for research and therapy, and also touch upon societal implications of this rapidly growing research field.
| Original language | English |
|---|---|
| Article number | 013006 |
| Number of pages | 6 |
| Journal | Convergent science physical oncology |
| Volume | 3 |
| Issue number | 1 |
| DOIs | |
| Publication status | Published - Mar-2017 |
Keywords
- epigenetics
- CRISPR/Cas
- breast cancer resistance
- ARTIFICIAL TRANSCRIPTION FACTORS
- ESTROGEN-RECEPTOR-ALPHA
- BREAST-CANCER
- DNA METHYLATION
- CERVICAL-CANCER
- HUMAN-DISEASE
- GENE
- DEMETHYLATION
- RESISTANCE
- EXPRESSION